@paulromzek_gmt's TRT confidence claims, fact-checked

What did @paulromzek_gmt actually say?

The creator laid out what he calls "the bare minimum supplement stack" for TRT clients running 200mg of testosterone weekly "without any side effects." His list included zinc, magnesium, vitamin D, high-dose fish oil (at least 3-4 grams EPA+DHA daily), CoQ10, nattokinase, citrus bergamot, and DIM. He also took a shot at doctors for "jerking around your dose and adding an AI" rather than optimizing for thriving. The bonus items, briefly flashed on screen, targeted insulin sensitivity and mitochondrial function.

The framing here matters. He's presenting this stack as something that prevents side effects at a fixed dose, not as general wellness support. That's a specific and testable claim, and it deserves scrutiny.

Does the science back this up?

Some of it does, some of it is overstated, and a couple of claims need real pushback. The fish oil recommendation has the strongest evidence base. The rest ranges from plausible to weakly supported.

On fish oil: a 2019 REDUCE-IT trial (Bhatt et al., New England Journal of Medicine) showed high-dose icosapentaenoic acid reduced cardiovascular events in high-risk patients, though debate exists about the mineral oil comparator. For lipid and triglyceride management, the evidence is solid. The claim about blood viscosity is less clean, but omega-3s do have anticoagulant properties.

CoQ10's role in the electron transport chain is textbook biochemistry. Statin-induced CoQ10 depletion is real and documented, though whether supplementation fully corrects this is still debated (Mortensen et al., 2014, JACC Heart Failure). The aging-related decline in endogenous CoQ10 is also well-established.

Nattokinase has some interesting data for fibrinolytic activity, but the claim that doses above 11,000 FU clear "fibrotic buildup" is getting ahead of the research. Most human studies are small and short-term. DIM's estrogen metabolism claims are biologically plausible but the clinical evidence in healthy men is thin.

What did they get wrong (or right)?

He got the fish oil and CoQ10 basics right. The statins-deplete-CoQ10 point is accurate and underemphasized in clinical practice. Credit where it's due.

But the claim that this stack lets clients run "200 milligrams a week without any side effects" is the kind of line that should raise flags. No supplement stack neutralizes the hematological, cardiovascular, or hormonal effects of supraphysiologic testosterone dosing. Polycythemia, for instance, is a direct dose-dependent response to exogenous testosterone and is not meaningfully mitigated by fish oil or nattokinase, even if those agents have mild blood-thinning properties.

The nattokinase claims are the weakest here. The 11,000 FU threshold for clearing "fibrotic buildup" is not well-supported by peer-reviewed human data. Most nattokinase studies use endpoints like blood pressure and D-dimer levels in small populations (Hsia et al., 2017, Scientific Reports). Presenting it as an anti-fibrotic agent with a clean dose threshold is speculative.

DIM's mechanism is real, but the clinical relevance for TRT patients, specifically whether shifting estrogen metabolites actually changes symptom burden or cardiovascular risk, has not been demonstrated in robust trials. The 2-hydroxyestrone vs. 16-hydroxyestrone framing is popular in functional medicine circles but remains contested in oncology literature (Zeleniuch-Jacquotte et al., 2004, International Journal of Cancer).

What should you actually know?

If you're on TRT, the idea of using supplements to support cardiovascular health and manage lipids is reasonable. The problem is the certainty with which this stack is presented as a side-effect prevention system. It isn't one, and treating it as such could give people a false sense of security about monitoring.

TRT at any dose requires regular bloodwork, including hematocrit, lipid panels, PSA, and liver enzymes. Supplements do not replace that monitoring, and the framing that your doctor is just making sure you're "not dying" rather than helping you thrive is a false binary. Aromatase inhibitor use in TRT is a real clinical tool, and dismissing it as lazy medicine is not accurate.

• Fish oil at 2-4g EPA+DHA daily has solid evidence for triglyceride reduction and modest cardiovascular benefit.
• CoQ10 supplementation is a reasonable call for anyone on statins, based on documented depletion mechanisms.
• Nattokinase evidence in humans is preliminary. Do not treat dose thresholds as clinical guidelines.
• DIM's estrogen pathway shift is mechanistically plausible but clinically unproven in TRT-specific populations.
• No supplement stack eliminates the need for regular labs on exogenous testosterone.